Q4 2023 Holdings
Filed 2024-02-14 | 22 holdings | $167.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Jasper Therapeutics Inc | COM | 471871103 | $28.9M | 3,659,255 | 17.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $13.3M | 35,000 | 7.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $12.5M | 309,950 | 7.4% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.6M | 489,938 | 6.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.1M | 241,961 | 6.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $10.1M | 141,348 | 6.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $9.2M | 659,035 | 5.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.0M | 150,000 | 5.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $8.7M | 143,479 | 5.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $8.0M | 100,862 | 4.8% |
| Merus NV | COM | N5749R100 | $7.6M | 274,923 | 4.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $6.8M | 357,271 | 4.1% |
| Geron Corp(GERN) | COM | 374163103 | $6.3M | 2,971,639 | 3.7% |
| Ambrx Biopharma Inc | COM | 641871108 | $5.5M | 385,383 | 3.3% |
| Avadel Pharmaceuticals | SPONSORED ADR | 05337M104 | $4.9M | 347,036 | 2.9% |
| Harpoon Therapeutics Inc | COM NEW | 41358P205 | $4.9M | 428,400 | 2.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.1M | 275,773 | 2.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.6M | 70,424 | 0.9% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $1.3M | 834,630 | 0.8% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $1.2M | 1,066,674 | 0.7% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $820.3K | 725,951 | 0.5% |
| Medavail Holdings Inc(MDVLQ) | COM NEW | 58406B202 | $529.4K | 117,897 | 0.3% |